Reciprocally, via positive feedback loops, MYC further upregulates cellular sumoylation in MYC-driven B-cell lymphomas by increasing the transcription of SUMO cascade enzymes [172]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.